Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement.

Importance Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardial infarction, stroke, and chronic kidney disease. Objective To reaffirm its 2015 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertension in adults, the accuracy of office blood pressure measurement for initial screening, and the accuracy of various confirmatory blood pressure measurement methods. Population Adults 18 years or older without known hypertension. Evidence Assessment Using a reaffirmation deliberation process, the USPSTF concludes with high certainty that screening for hypertension in adults has substantial net benefit. Recommendation The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement. The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment. (A recommendation).

[1]  Elizabeth M Webber,et al.  Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2021, JAMA.

[2]  J. Basile,et al.  Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association , 2020, Circulation.

[3]  Y. Ostchega,et al.  Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018. , 2020, NCHS data brief.

[4]  Deepak L. Bhatt,et al.  Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. , 2019, The New England journal of medicine.

[5]  P. Muntner,et al.  Should Out-of-Office Monitoring Be Performed for Detecting White Coat Hypertension? , 2019, Annals of Internal Medicine.

[6]  R. Townsend,et al.  Cardiovascular Events and Mortality in White Coat Hypertension , 2019, Annals of Internal Medicine.

[7]  Jackson T. Wright,et al.  Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. , 2019, Hypertension.

[8]  Douglas K Owens,et al.  Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[9]  Chyke A Doubeni,et al.  Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[10]  Wilbert S Aronow,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.

[11]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[12]  M. Phipps,et al.  Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement , 2017, JAMA.

[13]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[14]  J. Schwartz,et al.  Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure , 2017, American journal of epidemiology.

[15]  Yuli Huang,et al.  White-coat hypertension is a risk factor for cardiovascular diseases and total mortality , 2017, Journal of hypertension.

[16]  Douglas K Owens,et al.  Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[17]  Kirsten Bibbins-Domingo,et al.  Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. , 2016, Annals of internal medicine.

[18]  D. Tousoulis,et al.  White-coat hypertension and cardiovascular events: a meta-analysis , 2016, Journal of hypertension.

[19]  A. Siu Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. , 2015, Annals of internal medicine.

[20]  D. Conen,et al.  Age-Specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values , 2014, Hypertension.

[21]  E. O’Brien,et al.  Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population , 2014, Hypertension.

[22]  M. LeFevre,et al.  Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. , 2014, Annals of internal medicine.

[23]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[24]  V. Moyer Screening for Primary Hypertension in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement* , 2013, Annals of Internal Medicine.

[25]  L. Chambers,et al.  Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP) , 2011, BMJ : British Medical Journal.

[26]  S. Lewington Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[27]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[28]  C. Lenfant,et al.  National High Blood Pressure Education Program. , 1986, Journal of the American Optometric Association.

[29]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[30]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[31]  G. A. Leng ON POPULATION. , 1963, Singapore medical journal.